The Italian spin-out is one of the winners of the TechConnect Innovation Awards 2014.
Epinova Biotech is one of the recipients of a TechConnect Innovation Award, which it will officially receive during the TechConnect World Innovation Conference and Expo in Washington, DC. The conference will run from June 15 to 18.
Epinova is receiving the award for its Epigel product, a biotech tissue which helps regenerate damaged skin. Epinova is a spin-out from the School of Medicine of the University of Eastern Piedmont Amedeo Avogadro. The university is relatively young, having only been founded in 1998. The company, founded in April 2011, is based at Novara University’s Enne3 incubator.
Epigel, currently still a prototype, can address cell behaviour in reparation and cure skin tissues. Apart from treating wounds and scarring, the product has a huge potential in cosmetics.
Epinova previously won the Marzotto Prize when it took home €100,000 ($136,000) in December 2013 for coming first in one of the prize’s three categories. TechConnect is an annual award, split into two categories for companies with US funding and those without US funding, which honours the 65 best emerging technologies worldwide.
